Last update:
Oncology & Cancer news
Oncology & Cancer
Trump slashed US cancer research by 31 percent: Senate report
US President Donald Trump's administration slashed cancer research funding by 31% in the first three months of 2025 compared to the same period last year, according to a Senate report released Tuesday that accuses the White ...
43 minutes ago
0
0
Oncology & Cancer
Fragmented care does not affect survival outcomes for retroperitoneal sarcoma, says research
Fragmented care—receiving medical treatment at more than one facility—has been associated with both positive and negative outcomes for cancer patients depending on a number of factors such as cancer type and treatment ...
1 hour ago
0
0
Targeted approach to treating aggressive breast cancers shows significant improvement in survival
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.
4 hours ago
0
0
Computational framework reveals how cancers rewire driver genes to beat chemotherapy
Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few "driver" mutations give a cell a competitive edge and can spark cancer. Chemotherapy then adds ...
4 hours ago
0
2
Bioprinted organoids capture tumor features and predict prognosis based on shape
A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in vivo conditions of patient-derived cancer cells. This innovative model not only simulates the tumor ...
5 hours ago
0
0
High-dose radiotherapy can be safe and promising for lung cancer in combination with immunotherapy
Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy without increasing the risk of severe lung inflammation (pneumonitis). This is the key finding of a ...
2 hours ago
0
0
Researchers identify roles of key genes in colon cancer development
Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer development is not yet well ...
9 hours ago
0
0
Protein DNM1 identified as key regulator in ovarian cancer metastasis
Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because current treatments are not effective once the cancer has spread (metastasized) beyond the ovaries.
6 hours ago
0
8
'Cell line atlas' provides a crucial resource for developing therapies for biliary tract cancer
Advanced biliary tract cancer (BTC) includes cholangiocarcinoma, gallbladder carcinoma, and ampullary carcinoma. BTC is a rare and aggressive group of cancers, carrying one of the worst prognoses in all of oncology. Only ...
5 hours ago
0
0
Six breast texture patterns linked to higher risk of invasive cancer
In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a study published in Radiology.
5 hours ago
0
0
Experimental compound targets circadian clock machinery in cells to fight glioblastoma
A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma stem cells, impairing the cancer cells' ability to survive and grow. SHP1705 is also the first clock-targeting ...
23 hours ago
0
1
Vitamin supplements and cancer: New study warns against unsupervised nutritional interventions
A new study coordinated by Dr. Salvatore Cortellino and Professor Antonio Giordano, President of the Sbarro Health Research Organization (SHRO) and molecular oncologist at Temple University and the University of Siena, offers ...
22 hours ago
0
12
Promising results after CAR T-cell therapy for leukemia and lymphoma
Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in previous studies. This is shown in a new compilation of Swedish treatment results conducted by researchers ...
May 12, 2025
0
1
AI tool accurately sorts cancer patients by their likely outcomes
A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at ...
May 12, 2025
0
3
Genome-wide CRISPR screen identifies a novel target in NRAS-driven melanoma
Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a new therapeutic pathway for cancers driven by NRAS mutations. Findings suggest that interfering with ...
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the journal eClinicalMedicine finds that first-generation weight-loss medications like liraglutide and ...
May 12, 2025
0
11
CAR-T cell therapy for cancer causes 'brain fog,' study shows
After treatment with CAR-T cells—immune cells engineered to attack cancer—patients sometimes tell their doctors they feel like they have "brain fog," or forgetfulness and difficulty concentrating.
May 12, 2025
0
12
Shifting cell types in glioblastoma shed light on recurrence and possible therapy targets
Two research articles published in Nature Genetics shed new light on the cellular complexity of glioblastoma, the most aggressive type of brain cancer.
May 12, 2025
0
20
Cell-by-cell roadmap reveals key transcription-factor 'switches' in neuroblastoma
High-risk neuroblastoma kills roughly half of affected children because the tumor can switch cell identity and evade therapy. By combining single-cell multi-omics with spatial transcriptomics, researchers at Karolinska Institutet ...
May 12, 2025
0
0
Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients. The study published in The Journal of Molecular ...
May 12, 2025
0
0
Bevacizumab ovarian cancer trial: Real-world impact?
A real-world study based on information from an electronic health records–derived database reveals limited benefits of adding bevacizumab to first-line chemotherapy for patients with ovarian cancer, consistent with previous ...
May 12, 2025
0
0
Double lung transplant saves mother of twins
The timing of Cornelia Tischmacher's pneumonia couldn't have been worse—eight months after the Berlin mom gave birth to twins.
May 12, 2025
0
0
US approves first at-home cervical cancer screening device
The US Food and Drug Administration has approved an at-home cervical cancer screening tool as an alternative to Pap smears by a gynecologist, the company behind the device said Friday.
May 10, 2025
0
0
Fat-rich fluid found to fuel immune failure in ovarian cancer
New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new insights ...
May 9, 2025
0
58
Novel cancer immunotherapy offers new hope for late-stage cancer patients
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG have announced promising outcomes from a Phase II clinical trial of a novel cancer immunotherapy, ...
May 9, 2025
0
27
